# Eric L. Simpson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eric-l-simpson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,811 |
| Field | Dermatology and Skin Diseases |
| h-index | 54 |
| i10-index | 112 |
| Last Known Institution | Oregon Health & Science University |
| OpenAlex ID | https://openalex.org/A5102805192 |
| ORCID iD | 0000-0002-8793-7087 |
| Works | 265 |

## Researcher papers

Showing 12 of 15.

- [Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis](https://scholariq.org/papers/dupilumab-treatment-in-adults-with-moderate-to-severe-atopic-dermatitis/)
- [Guidelines of care for the management of atopic dermatitis](https://scholariq.org/papers/guidelines-of-care-for-the-management-of-atopic-dermatitis-2/)
- [Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial](https://scholariq.org/papers/long-term-management-of-moderate-to-severe-atopic-dermatitis-with-dupilumab-and/)
- [Guidelines of care for the management of atopic dermatitis](https://scholariq.org/papers/guidelines-of-care-for-the-management-of-atopic-dermatitis-3/)
- [Epidemiology of atopic dermatitis in adults: Results from an international survey](https://scholariq.org/papers/epidemiology-of-atopic-dermatitis-in-adults-results-from-an-international-survey/)
- [Guidelines of care for the management of atopic dermatitis](https://scholariq.org/papers/guidelines-of-care-for-the-management-of-atopic-dermatitis/)
- [Patient burden and quality of life in atopic dermatitis in US adults](https://scholariq.org/papers/patient-burden-and-quality-of-life-in-atopic-dermatitis-in-us-adults/)
- [Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial](https://scholariq.org/papers/efficacy-and-safety-of-dupilumab-in-adults-with-moderate-to-severe-atopic/)
- [Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population](https://scholariq.org/papers/atopic-dermatitis-in-america-study-a-cross-sectional-study-examining-the/)
- [Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials](https://scholariq.org/papers/baricitinib-in-patients-with-moderate-to-severe-atopic-dermatitis-and-inadequate/)
- [The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials](https://scholariq.org/papers/the-harmonising-outcome-measures-for-eczema-home-statement-to-assess-clinical/)
- [The Harmonizing Outcome Measures for Eczema (HOME) Roadmap: A Methodological Framework to Develop Core Sets of Outcome Measurements in Dermatology](https://scholariq.org/papers/the-harmonizing-outcome-measures-for-eczema-home-roadmap-a-methodological/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Food Allergy and Anaphylaxis Research](https://scholariq.org/topics/food-allergy-and-anaphylaxis-research/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)

## Researcher university

- [Oregon Health & Science University](https://scholariq.org/institutions/oregon-health-and-science-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.